Zimmer Biomet Secures Global Distribution Agreement with CelgenTek

By Julie A. Vetalice

Zimmer Biomet entered into an exclusive global distribution agreement for CelgenTek Innovations' N-Force Fixation System® and iN3 Cement.

This agreement allows healthcare professionals to directly administer N-Force Blue­­ Bone Substitute Material (available in the U.S.) and iN3 Cement (available in the EU) directly through a fenestrated screw in a single integrated construct.

CelgenTek's subsidiaries include Memphis, TN-based InnoVision and Shannon, Ireland-based CelgenTek, manufacturer of the N-Force Fixation System and iN3 Cement.  N-Force is FDA-cleared in the U.S. and EU, while iN3 cement is available in the EU.

Source: Zimmer Biomet, Inc.